William J. Sandborn, See Remarks at Ventyx Biosciences, Inc. (VTYX), sold 21,580 shares at $37.40 ($798K) on 2023-04-28, disclosed to the SEC on 2023-05-01.
Open-market sale of $798k VTYX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.17 | 3,886 | $141K | 17.6% |
| 2 | $36.17 | 3,886 | $141K | 17.6% |
| 3 | $37.40 | 6,904 | $258K | 32.4% |
| 4 | $37.40 | 6,904 | $258K | 32.4% |
| Total | $36.96 avg | 21,580 | $798K | 100% |
| Filing → |
| VTYX | SELL | 2023-08-01 | $884K | — | Filing → |
| VTYX | SELL | 2023-07-05 | $615K | — | Filing → |
| VTYX | SELL | 2023-06-27 | $706K | — | Filing → |